No statistically significant differences were observed between patients with minimal change disease and those with focal segmental glomerulosclerosis in terms of podocyte GR expression (P = 0.299) (Supplementary Figure S2) or time to remission (0.053) (Table 1). Here, NR3C1 is linked to focal segmental glomerulosclerosis.